UK markets closed

Black Diamond Therapeutics, Inc. (BDTX)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
5.89+0.78 (+15.26%)
At close: 04:00PM EDT
5.87 -0.02 (-0.34%)
After hours: 07:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
59,350
59,350
64,437
96,829
48,209
Selling general and administrative
27,110
27,110
28,391
30,043
21,361
Total operating expenses
86,460
86,460
92,828
126,872
69,570
Operating income or loss
-86,460
-86,460
-92,828
-126,872
-69,570
Interest expense
-
-
-
0
1
Total other income/expenses net
2,094
2,094
-372
-2,188
-1,724
Income before tax
-82,442
-82,442
-91,169
-125,596
-67,254
Income from continuing operations
-82,442
-82,442
-91,169
-125,596
-67,254
Net income
-82,442
-82,442
-91,169
-125,596
-67,254
Net income available to common shareholders
-82,442
-82,442
-91,169
-125,596
-67,254
Basic EPS
-2.13
-
-2.52
-3.47
-2.05
Diluted EPS
-2.13
-
-2.52
-3.47
-2.05
Basic average shares
40,123
-
36,230
36,189
32,907
Diluted average shares
40,123
-
36,230
36,189
32,907